Morgan Stanley Maintains Equal-Weight on Merck & Co, Raises Price Target to $118
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Merck & Co (NYSE:MRK) and raised the price target from $115 to $118.
October 27, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Merck & Co and raised the price target from $115 to $118.
The news is directly related to Merck & Co and is likely to have a positive impact on its stock price in the short term. The increase in the price target by Morgan Stanley indicates a positive outlook for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100